Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating repetitive transcranial magnetic stimulation (rTMS) and the P50 evoked potential component in depression and schizophrenia has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Schizophrenia

Snippet

Sponsor: University Hospital, Caen | Conditions: Depression, Schizophrenia | Phase 2 | Status: COMPLETED